GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 98 filers reported holding GOSSAMER BIO INC in Q1 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,644 | +38.8% | 44,000 | +100.0% | 0.00% | -50.0% |
| Q2 2023 | $26,400 | -4.8% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $27,720 | +265.0% | 22,000 | +528.6% | 0.00% | +100.0% |
| Q4 2022 | $7,595 | -81.9% | 3,500 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $42,000 | +44.8% | 3,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | -3.3% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -25.0% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $40,000 | -9.1% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $44,000 | +57.1% | 3,500 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $28,000 | -12.5% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $32,000 | -5.9% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $34,000 | +183.3% | 3,500 | +250.0% | 0.00% | +200.0% |
| Q3 2020 | $12,000 | -7.7% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |